FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107334598> ?p ?o ?g. }

• W2107334598 abstract "Sickle cell disease is one of the most common genetic disorders. Sickle cell crises in which irregular and dehydrated cells contribute to blocking of blood vessels are characterised by episodes of pain. Treatment is mainly supportive and symptomatic. In vitro studies with piracetam indicate that it has the potential for inhibition and a reversal of the process of sickling of erythrocytes. This is an update of a previously published Cochrane review.To assess the effectiveness of piracetam for reducing the incidence of painful sickle cell disease crises.We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Haemoglobinopathies Trials Register which comprises of references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings.Last search of the Group's Haemoglobinopathies Trials Register: 21 September 2015.Randomised controlled trials comparing orally administered piracetam to placebo or standard care in people, of all ages and both sexes, with sickle cell disease.Two authors independently assessed trial quality and extracted data. Trial authors were contacted for additional information. Adverse effects data were collected from the trials.Three trials involving 169 participants were included in the review. A limited amount of data addressing some of the primary and some of the secondary outcomes were provided, but data were incomplete and based on un-validated assumptions used in the evaluation of outcomes. One trial reported a reduction in the number of pain crises and their severity with active intervention than placebo but presented no data to confirm these results. A second trial presented a monthly global pain score based on the number of sickle cell crises and severity of pain but included no separate data for these primary outcomes. Although there was no significant difference between the piracetam and placebo periods for the number of days of hospitalisation (P = 0.87) in one trial, inconsistencies in the criteria necessary for hospitalisation during sickle crises did not permit accurate conclusions to be drawn. Two of the trials reported participant satisfaction with piracetam but provided no details as to how this satisfaction had been assessed. There were no reports of toxicity or adverse effects with piracetam other than one participant who experienced dizziness.The small number of included trials and their poor methodological quality provided insufficient reliable evidence to support the routine use of this medication for preventing the incidence of painful sickle cell disease crises.We will continue to run searches to identify any potentially relevant trials; however, we do not plan to update other sections of the review until new trials are published." @default.
• W2107334598 created "2016-06-24" @default.
• W2107334598 creator A5045912789 @default.
• W2107334598 creator A5075316065 @default.
• W2107334598 date "2016-02-12" @default.
• W2107334598 modified "2023-10-16" @default.
• W2107334598 title "Piracetam for reducing the incidence of painful sickle cell disease crises" @default.
• W2107334598 cites W136157357 @default.
• W2107334598 cites W1566270415 @default.
• W2107334598 cites W1567285005 @default.
• W2107334598 cites W1719378198 @default.
• W2107334598 cites W1727437819 @default.
• W2107334598 cites W1862687306 @default.
• W2107334598 cites W1951816138 @default.
• W2107334598 cites W1979032722 @default.
• W2107334598 cites W1987758775 @default.
• W2107334598 cites W1995274771 @default.
• W2107334598 cites W1995500400 @default.
• W2107334598 cites W2000705276 @default.
• W2107334598 cites W2008680645 @default.
• W2107334598 cites W2011060742 @default.
• W2107334598 cites W2033656027 @default.
• W2107334598 cites W2037704462 @default.
• W2107334598 cites W2048576485 @default.
• W2107334598 cites W2069048417 @default.
• W2107334598 cites W2070502382 @default.
• W2107334598 cites W2076272528 @default.
• W2107334598 cites W2077558381 @default.
• W2107334598 cites W2130235475 @default.
• W2107334598 cites W2530359252 @default.
• W2107334598 cites W30546507 @default.
• W2107334598 cites W3081511334 @default.
• W2107334598 cites W3113247834 @default.
• W2107334598 cites W96680208 @default.
• W2107334598 doi "https://doi.org/10.1002/14651858.cd006111.pub3" @default.
• W2107334598 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7390168" @default.
• W2107334598 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26869149" @default.
• W2107334598 hasPublicationYear "2016" @default.
• W2107334598 type Work @default.
• W2107334598 sameAs 2107334598 @default.
• W2107334598 citedByCount "7" @default.
• W2107334598 countsByYear W21073345982012 @default.
• W2107334598 countsByYear W21073345982016 @default.
• W2107334598 countsByYear W21073345982018 @default.
• W2107334598 countsByYear W21073345982019 @default.
• W2107334598 countsByYear W21073345982023 @default.
• W2107334598 crossrefType "journal-article" @default.
• W2107334598 hasAuthorship W2107334598A5045912789 @default.
• W2107334598 hasAuthorship W2107334598A5075316065 @default.
• W2107334598 hasBestOaLocation W21073345982 @default.
• W2107334598 hasConcept C120665830 @default.
• W2107334598 hasConcept C121332964 @default.
• W2107334598 hasConcept C126322002 @default.
• W2107334598 hasConcept C142724271 @default.
• W2107334598 hasConcept C168563851 @default.
• W2107334598 hasConcept C177713679 @default.
• W2107334598 hasConcept C1862650 @default.
• W2107334598 hasConcept C187212893 @default.
• W2107334598 hasConcept C197934379 @default.
• W2107334598 hasConcept C204787440 @default.
• W2107334598 hasConcept C27081682 @default.
• W2107334598 hasConcept C2776478404 @default.
• W2107334598 hasConcept C2777496795 @default.
• W2107334598 hasConcept C2779134260 @default.
• W2107334598 hasConcept C535046627 @default.
• W2107334598 hasConcept C61511704 @default.
• W2107334598 hasConcept C71924100 @default.
• W2107334598 hasConcept C95190672 @default.
• W2107334598 hasConcept C98274493 @default.
• W2107334598 hasConceptScore W2107334598C120665830 @default.
• W2107334598 hasConceptScore W2107334598C121332964 @default.
• W2107334598 hasConceptScore W2107334598C126322002 @default.
• W2107334598 hasConceptScore W2107334598C142724271 @default.
• W2107334598 hasConceptScore W2107334598C168563851 @default.
• W2107334598 hasConceptScore W2107334598C177713679 @default.
• W2107334598 hasConceptScore W2107334598C1862650 @default.
• W2107334598 hasConceptScore W2107334598C187212893 @default.
• W2107334598 hasConceptScore W2107334598C197934379 @default.
• W2107334598 hasConceptScore W2107334598C204787440 @default.
• W2107334598 hasConceptScore W2107334598C27081682 @default.
• W2107334598 hasConceptScore W2107334598C2776478404 @default.
• W2107334598 hasConceptScore W2107334598C2777496795 @default.
• W2107334598 hasConceptScore W2107334598C2779134260 @default.
• W2107334598 hasConceptScore W2107334598C535046627 @default.
• W2107334598 hasConceptScore W2107334598C61511704 @default.
• W2107334598 hasConceptScore W2107334598C71924100 @default.
• W2107334598 hasConceptScore W2107334598C95190672 @default.
• W2107334598 hasConceptScore W2107334598C98274493 @default.
• W2107334598 hasLocation W21073345981 @default.
• W2107334598 hasLocation W21073345982 @default.
• W2107334598 hasLocation W21073345983 @default.
• W2107334598 hasOpenAccess W2107334598 @default.
• W2107334598 hasPrimaryLocation W21073345981 @default.
• W2107334598 hasRelatedWork W1566270415 @default.
• W2107334598 hasRelatedWork W1602115818 @default.
• W2107334598 hasRelatedWork W1733091397 @default.
• W2107334598 hasRelatedWork W1901102297 @default.
• W2107334598 hasRelatedWork W1947768043 @default.
• W2107334598 hasRelatedWork W1977605568 @default.
• W2107334598 hasRelatedWork W2029911648 @default.

• next